This inventor holds 1 USPTO granted patent and 3 published patent applications and 4 EPO patents. Top assignees: Charité – Universitätsmedizin Berlin, Freie Universitat Berlin. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:

Years Active: 2026
Title: The Innovations of Daniel Lauster
Introduction
Daniel Lauster is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of medical treatments through his innovative research and patents. His work focuses on improving the quality of life for patients suffering from various respiratory and gastrointestinal conditions.
Latest Patents
Lauster holds a patent for "Medical uses of thiol-functionalized polyglycerol derivatives." This patent describes a method for treating patients in need of reducing mucus viscosity. The treatment involves administering a polyglycerol derivative that has a linear or dendritic polyglycerol backbone, which carries at least one thiol group. This innovative approach is particularly beneficial for patients suffering from chronic sinusitis, asthma, chronic bronchitis, cystic fibrosis, chronic obstructive pulmonary disease, emphysema, bronchiectasis, chronic inflammatory bowel diseases, constipation, gastrointestinal malabsorption syndrome, irritable bowel syndrome, steatorrhea, or diarrhea.
Career Highlights
Throughout his career, Lauster has worked with prestigious institutions such as Freie Universität Berlin and Charité – Universitätsmedizin Berlin. His research has led to advancements in medical treatments, showcasing his dedication to improving patient care.
Collaborations
Lauster has collaborated with notable colleagues, including Yinan Zhong and Rainer Haag. These partnerships have contributed to the success of his research and the development of his patented methods.
Conclusion
Daniel Lauster's innovative work in the medical field highlights the importance of research and development in improving patient outcomes. His contributions through his patent demonstrate a commitment to addressing significant health challenges.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile